Preclinical and clinical models of lung cancer chemoprevention.

[1]  T. Yun,et al.  Experimental and epidemiological evidence of the cancer-preventive effects of Panax ginseng C.A. Meyer. , 2009, Nutrition reviews.

[2]  L. Dwyer-Nield,et al.  Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung tumor formation by FGN-1 (sulindac sulfone). , 1998, Carcinogenesis.

[3]  V. Steele,et al.  Chemoprevention of pulmonary carcinogenesis by aerosolized budesonide in female A/J mice. , 1997, Cancer research.

[4]  M. Sporn,et al.  Recent advances in chemoprevention of cancer. , 1997, Science.

[5]  W. Hong,et al.  Retinoids in Head and Neck Chemoprevention , 1997, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[6]  R. Maronpot,et al.  The carcinogenic potential of the gas phase of environmental tobacco smoke. , 1997, Carcinogenesis.

[7]  Y. Miller,et al.  Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis. , 1997, The Journal of clinical investigation.

[8]  T. Dragani,et al.  Association of chromosome 12p genetic polymorphisms with lung adenocarcinoma risk and prognosis. , 1997, Carcinogenesis.

[9]  R. Estensen,et al.  Studies of chemopreventive effects of budenoside on benzo[a]pyrene-induced neoplasia of the lung of female A/J mice. , 1997, Carcinogenesis.

[10]  V. Jordan.  Tamoxifen: the herald of a new era of preventive therapeutics. , 1997, Journal of the National Cancer Institute.

[11]  F. Khuri,et al.  Chemoprevention of respiratory tract cancer. , 1997, Hematology/oncology clinics of North America.

[12]  A. Castonguay,et al.  Chemopreventive efficacies of aspirin and sulindac against lung tumorigenesis in A/J mice. , 1997, Carcinogenesis.

[13]  R. Maronpot,et al.  The carcinogenicity of environmental tobacco smoke. , 1997, Carcinogenesis.

[14]  M. Spitz,et al.  Molecular epidemiology and retinoid chemoprevention of head and neck cancer. , 1997, Journal of the National Cancer Institute.

[15]  G. Stoner,et al.  Inhibition of lung tumor cell growth in vitro and mouse lung tumor formation by lovastatin. , 1996, Cancer letters.

[16]  R. Estensen,et al.  Chemopreventive effects of myo-inositol and dexamethasone on benzo[a]pyrene and 4-(methylnitrosoamino)-1-(3-pyridyl)-1-butanone-induced pulmonary carcinogenesis in female A/J mice. , 1996, Cancer research.

[17]  M R Cullen,et al.  Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. , 1996, Journal of the National Cancer Institute.

[18]  Stephen Leeder.  Scientific Basis of Health Services , 1996, Springer US.

[19]  Bin Chen,et al.  Loss of heterozygosity on chromosomes 1, 11, 12, and 14 in hybrid mouse lung adenocarcinomas , 1996, Molecular carcinogenesis.

[20]  G. Omenn,et al.  Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. , 1996, The New England journal of medicine.

[21]  J. Manson,et al.  Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. , 1996, The New England journal of medicine.

[22]  C. Galán,et al.  Glutathione-S-Transferase M1 and codon 72 p53 polymorphisms in a northwestern Mediterranean population and their relation to lung cancer susceptibility. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[23]  M. King,et al.  Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden. , 1996, American journal of human genetics.

[24]  David B. Holiday,et al.  Beta-Carotene, vitamin A, and lung cancer chemoprevention: results of an intermediate endpoint study. , 1995, The American journal of clinical nutrition.

[25]  J. Minna,et al.  Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers. , 1995, Journal of the National Cancer Institute.

[26]  J. Herman,et al.  5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers , 1995, Nature Medicine.

[27]  G. Stoner,et al.  Failure of dietary oltipraz to inhibit benzo[a]pyrene-induced lung tumorigenesis in strain a mice. , 1995, Cancer letters.

[28]  Y. Lee,et al.  Trial of a new medium-term model using benzo(a)pyrene induced lung tumor in newborn mice. , 1995, Anticancer research.

[29]  J. Yokota,et al.  Frequent allelic losses on chromosomes 2q, 18q, and 22q in advanced non-small cell lung carcinoma. , 1994, Cancer research.

[30]  S. Amin,et al.  Structure-activity relationships of isothiocyanates as mechanism-based inhibitors of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice. , 1994, Cancer research.

[31]  A. Galbraith,et al.  Inhibition of carcinogen-induced pulmonary and mammary carcinogenesis by chalcone administered subsequent to carcinogen exposure. , 1994, Cancer letters.

[32]  S. Lippman,et al.  Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  V. Steele,et al.  Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trials. , 1994, Cancer research.

[34]  J. German.  Bloom Syndrome: A Mendelian Prototype of Somatic Mutational Disease , 1993, Medicine.

[35]  R. Metcalf,et al.  p53 protein accumulates frequently in early bronchial neoplasia. , 1993, Cancer research.

[36]  R. Estensen,et al.  Studies of chemopreventive effects of myo-inositol on benzo[a]pyrene-induced neoplasia of the lung and forestomach of female A/J mice. , 1993, Carcinogenesis.

[37]  S. Hecht,et al.  Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone mouse lung tumorigenesis by arylalkynes, mechanism-based inactivators of cytochrome P450. , 1993, Carcinogenesis.

[38]  M Buyse,et al.  Adjuvant treatment of stage I lung cancer with high-dose vitamin A. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  A E Profio,et al.  Detection of dysplasia and carcinoma in situ with a lung imaging fluorescence endoscope device. , 1993, The Journal of thoracic and cardiovascular surgery.

[40]  J. Minna.  The molecular biology of lung cancer pathogenesis. , 1993, Chest.

[41]  W. Beckett.  Epidemiology and etiology of lung cancer. , 1993, Clinics in chest medicine.

[42]  M. Humbert,et al.  Serum neopterin after lung transplantation. , 1993, Chest.

[43]  R. Hermus,et al.  Beta-carotene supplementation in smokers reduces the frequency of micronuclei in sputum. , 1992, British Journal of Cancer.

[44]  A. Conney,et al.  Inhibitory effect of green tea on the growth of established skin papillomas in mice. , 1992, Cancer research.

[45]  R. Hoover,et al.  The debrisoquine metabolic phenotype and DNA-based assays: implications of misclassification for the association of lung cancer and the debrisoquine metabolic phenotype. , 1992, Environmental health perspectives.

[46]  U. Pastorino,et al.  Deletions of 17p and p53 mutations in preneoplastic lesions of the lung. , 1992, Cancer research.

[47]  A. Castonguay,et al.  Effects of NSAIDs on NNK-induced pulmonary and gastric tumorigenesis in A/J mice. , 1992, Cancer letters.

[48]  S. Amin,et al.  Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone pulmonary metabolism and tumorigenicity in mice by analogues of the investigational chemotherapeutic drug 4-ipomeanol. , 1992, Chemical research in toxicology.

[49]  S. Amin,et al.  Inhibition of tobacco-specific nitrosamine-induced lung tumorigenesis in A/J mice by green tea and its major polyphenol as antioxidants. , 1992, Cancer research.

[50]  S. Shi,et al.  Inhibitory effects of diallyl sulfide on the metabolism and tumorigenicity of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in A/J mouse lung. , 1992, Carcinogenesis.

[51]  Y. Lee,et al.  Inhibitory effects of biochanin A on benzo(a)pyrene induced carcinogenesis in mice. , 1992, In vivo.

[52]  A. Malkinson.  Primary lung tumors in mice: an experimentally manipulable model of human adenocarcinoma. , 1992, Cancer research.

[53]  L. Booker,et al.  The effect of the synthetic retinoid etretinate on sputum cytology: results from a randomised trial. , 1992, British Journal of Cancer.

[54]  Jun-yan Hong,et al.  Inhibition of N-nitrosodiethylamine- and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced tumorigenesis in A/J mice by green tea and black tea. , 1992, Cancer research.

[55]  T. Pechacek,et al.  Smoking-attributable cancer mortality in 1991: is lung cancer now the leading cause of death among smokers in the United States? , 1991, Journal of the National Cancer Institute.

[56]  G E Moore,et al.  Absence of retinoblastoma protein expression in primary non-small cell lung carcinomas. , 1991, Cancer research.

[57]  S. Amin,et al.  Structure-activity relationships for inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone lung tumorigenesis by arylalkyl isothiocyanates in A/J mice. , 1991, Cancer research.

[58]  G. Stoner,et al.  Lung tumorigenicity of NNK given orally to A/J mice: its application to chemopreventive efficacy studies. , 1991, Experimental lung research.

[59]  J. Minna,et al.  Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group. , 1990, Oncogene.

[60]  L J Peters,et al.  Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. , 1990, The New England journal of medicine.

[61]  K. Toyoda,et al.  Inhibitory Effects of Antioxidants on N‐Bis(2‐hydroxypropyl)nitrosamine‐induced Lung Carcinogenesis in Rats , 1990, Japanese journal of cancer research : Gann.

[62]  T. Sellers,et al.  Evidence for mendelian inheritance in the pathogenesis of lung cancer. , 1990, Journal of the National Cancer Institute.

[63]  S. Amin,et al.  Effects of indole-3-carbinol on lung tumorigenesis and DNA methylation induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and on the metabolism and disposition of NNK in A/J mice. , 1990, Cancer research.

[64]  R. Hoover,et al.  Association of rare alleles of the Harvey ras protooncogene locus with lung cancer. , 1990, Cancer research.

[65]  H. Mukhtar,et al.  Effect of dietary tannic acid on epidermal, lung, and forestomach polycyclic aromatic hydrocarbon metabolism and tumorigenicity in Sencar mice. , 1989, Cancer research.

[66]  S. Amin,et al.  Effects of alkyl chain length on the inhibition of NNK-induced lung neoplasia in A/J mice by arylalkyl isothiocyanates. , 1989, Carcinogenesis.

[67]  G. Draper,et al.  Non-ocular cancer in relatives of retinoblastoma patients. , 1989, British Journal of Cancer.

[68]  S. Amin,et al.  Effects of aromatic isothiocyanates on tumorigenicity, O6-methylguanine formation, and metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in A/J mouse lung. , 1989, Cancer research.

[69]  Marshall W. Anderson,et al.  Activation of the Ki-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[70]  A. Malkinson.  The genetic basis of susceptibility to lung tumors in mice. , 1989, Toxicology.

[71]  S. Rodenhuis,et al.  Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. , 1988, Cancer research.

[72]  W. Blattner,et al.  A cancer family syndrome in twenty-four kindreds. , 1988, Cancer research.

[73]  D. Heimburger,et al.  Improvement in bronchial squamous metaplasia in smokers treated with folate and vitamin B12. Report of a preliminary randomized, double-blind intervention trial. , 1988, JAMA.

[74]  T. Sellers,et al.  Increased familial risk for non-lung cancer among relatives of lung cancer patients. , 1987, American journal of epidemiology.

[75]  L. Wattenberg.  Protective effects of 2(3)-tert-butyl-4-hydroxyanisole on chemical carcinogenesis. , 1986, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[76]  W. Kimberling,et al.  Genetics and smoking‐associated cancers. A study of 485 families , 1986, Cancer.

[77]  J. Fielding.  Smoking: Health Effects and Control , 1985 .

[78]  K. Weiss,et al.  Cancer mortality in relatives of retinoblastoma patients. , 1984, Journal of the National Cancer Institute.

[79]  W. Willett,et al.  Diet and cancer--an overview. , 1984, The New England journal of medicine.

[80]  P. Lesca.  Protective effects of ellagic acid and other plant phenols on benzo[a]pyrene-induced neoplasia in mice. , 1983, Carcinogenesis.

[81]  A. Verma,et al.  Inhibition of 7-bromomethylbenz[a]anthracene-promoted mouse skin tumor formation by retinoic acid and dexamethasone. , 1983, Cancer research.

[82]  J. Mulvihill,et al.  Familial respiratory tract cancer. Opportunities for research and prevention. , 1982, JAMA.

[83]  L. Wattenberg.  Inhibition of polycyclic aromatic hydrocarbon-induced neoplasia by sodium cyanate. , 1980, Cancer research.

[84]  S. Belman,et al.  The inhibition of croton oil-promoted mouse skin tumorigenesis by steroid hormones. , 1972, Cancer research.

[85]  L. Wattenberg,et al.  Inhibition of the carcinogenic action of benzo(a)pyrene by flavones. , 1970, Cancer research.

[86]  A. Lilienfeld,et al.  Familial aggregation of lung cancer in humans. , 1963, Journal of the National Cancer Institute.

[87]  R. Doll,et al.  A study of the aetiology of carcinoma of the lung. , 1953, Pakistan journal of health.

[88]  K. Svenson,et al.  Additional evidence that the K-ras protooncogene is a candidate for the major mouse pulmonary adenoma susceptibility (Pas-1) gene. , 1998, Experimental lung research.

[89]  J. Siegfried.  Biology and chemoprevention of lung cancer. , 1998, Chest.

[90]  M. You,et al.  Chemopreventive effect of perillyl alcohol on 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanone induced tumorigenesis in (C3H/HeJ X A/J)F1 mouse lung , 1997, Journal of cellular biochemistry. Supplement.

[91]  M. You,et al.  Genetic alterations in mouse lung tumors: Implications for cancer chemoprevention , 1997, Journal of cellular biochemistry. Supplement.

[92]  C. Boone,et al.  Biomarker end-points in cancer chemoprevention trials. , 1997, IARC scientific publications.

[93]  D. Albanes,et al.  The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. , 1994, The New England journal of medicine.

[94]  J. Minna,et al.  Molecular genetic changes found in human lung cancer and its precursor lesions. , 1994, Cold Spring Harbor symposia on quantitative biology.

[95]  M. Boukharta,et al.  Biodistribution of ellagic acid and dose-related inhibition of lung tumorigenesis in A/J mice. , 1992, Nutrition and cancer.

[96]  H. McDuffie,et al.  Clustering of cancer in families of patients with primary lung cancer. , 1991, Journal of clinical epidemiology.

[97]  T J Mason,et al.  Lung cancer risk associated with cancer in relatives. , 1991, Journal of clinical epidemiology.

[98]  L. Wattenberg,et al.  Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone carcinogenesis in mice by D-limonene and citrus fruit oils. , 1991, Carcinogenesis.

[99]  L. Wattenberg.  Chemoprevention of cancer. , 1985, Cancer research.

[100]  D. Brian,et al.  Effects of 13-CIS retinoids on premalignant and malignant cells of lung origin. , 1982, Acta cytologica.

[101]  J. Misset,et al.  Correlation between precancerous bronchial metaplasia and cigarette consumption, and preliminary results of retinoid treatment. , 1982, Cancer detection and prevention.